Serum Eosinophilic Cationic Protein (ECP) in Asthmatic Malaysian Children

P W K Chan1, H H Samsinah, H Z Arpin

  • 1University Hospital, Department of Paediatrics, 50603 Kuala Lumpur, Malaysia.

Insights

Serum eosinophilic cationic protein (ECP) levels were significantly higher in asthmatic children compared to controls. Elevated ECP may aid in diagnosing childhood asthma in Malaysia.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Eosinophilic inflammation is a key factor in childhood asthma development.
  • Serum eosinophilic cationic protein (ECP) serves as a reliable marker for eosinophil activation.

Purpose of the Study:

  • To investigate serum ECP levels in children with asthma.
  • To assess the utility of serum ECP as a diagnostic marker for childhood asthma in Malaysia.

Main Methods:

  • Serum ECP was measured in 20 asthmatic children and 19 non-asthmatic controls.
  • Demographic data, passive smoke exposure, urinary cotinine, and family history were compared between groups.

Main Results:

  • No significant differences were found in socio-demographics, smoke exposure, or family history between groups.
  • Median serum ECP was significantly higher in asthmatic children (27.0 mcg/L) versus controls (5.9 mcg/L), with p=0.002.

Conclusions:

  • Serum ECP levels are elevated in children with asthma.
  • Elevated serum ECP can provide supportive evidence for diagnosing childhood bronchial asthma in the Malaysian population.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K